GSK rises on news of divestment plans
GlaxoSmithKline (GSK) is planning to divest the consumer healthcare unit it shares with Pfizer (PFE). Reports suggest the unit could be worth £40 billion which is large considering GSK has a market cap of £70.4bln.
Related articles
Live prices on most popular markets
- Equities
- Indices
- Forex
- Commodities
Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.